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Introduction
Hypertension (HTN) is common in the general
population. Noncommunicable diseases like HTN are amongst
the top ten causes of mortality and morbidity in Pakistan and
account for 25% of the total deaths within the country.1 The
National Health Survey of Pakistan reported that 21.5% of the
urban population over 15 years (one in every three persons
over the age of 45) suffers from HTN.2 Studies have shown that
HTN increases risks of major cardiovascular events
(cardiovascular death, myocardial infarction and stroke) and
renal failure.3 Hypertension for Pakistan, therefore, is a major
health budget and disease prevention concern.
Whilst standard BP measurements by cuff are of value
in large populations, they might be unreliable in individuals
as BP may vary between consecutive measurements or when
measured at different times.4 Clinicians are often presented
with patients with "labile blood pressure", who initially have
raised blood pressure that subsequently falls over a period of
time or varies considerably between visits. The reduction in
BP over time may also be due to specific non-
pharmacological measures initiated by the patient such as salt
restriction, weight reduction or an increase in physical
activity.5 Thus the diagnosis of HTN and the decision to
initiate antihypertensive medication is often difficult, given
this inherent variability of blood pressure. 
White Coat Hypertension (WCH) is one such
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Abstract
Objectives: To determine the frequency of White Coat Hypertension in patients undergoing ambulatory blood
pressure monitoring at a tertiary care center and to compare ambulatory blood pressure profiles of
normotensives , white coat hypertensives and hypertensives. 
Methods: A descriptive cross-sectional study was conducted which included all adult patients undergoing
ambulatory blood pressure monitoring over a 3-year period. Those patients with incomplete data, less than
85% successful BP readings and inadequate number of daytime and nighttime readings were excluded
from the study. The data on ambulatory blood pressure monitoring comprised of demographics, blood
pressure, pulse pressure and mean arterial pressure readings at every 30 minutes interval and also a
graphical representation of patients' 24-hour blood pressure recording. SPSS was used for data analysis.
Chi-square test and analysis of variance (ANOVA) was used for qualitative and quantitative variables
respectively.
Results: A total of 277 patients with a mean age of 48.98±17.52 years were included. There were 189 (58%)
males included in the study. Out of the total, 46 (16.6%) patients had White Coat Hypertension, 59 (21.3%) were
Normotensive and 172 (62.1%) had Hypertension. The mean age of Normotensives was 40.80±14.11 years,
White Coat Hypertensives was 37.72±14.58 years and Hypertensives was 54.80±16.76 years (p <0.001). The
overall average Systolic Blood Pressure in Normotensives was 118.69±6.61mm Hg in White Coat Hypertensives
120.57±6.71mmHg and in Hypertensives it was 131.18±13.14mm Hg (p<0.001). The overall systolic load in
Normotensives was 12.98±15.21, White Coat Hypertensives 15.86±14.12 and Hypertensives 41.71±28.21 (p
value<0.001). The Mean Arterial Pressure in Normotensives was 90.17±5.02mm Hg, in White Coat
Hypertensives 90.17±5.08 mmHg and in Hypertensives it was 96.08±9.21mm Hg (p <0.001). The average Pulse
Pressure in Normotensives was 43.56±6.29, White Coat Hypertensives 46.20±6.49 and in Hypertensives it was
54.65±12.86 (p <0.001).
Conclusion: Our study has shown a frequency of White Coat Hypertension, which is similar to many populations
globally. All parameters of hypertension are more prevalent in this group compared to normotensives, which
signifies that White Coat Hypertension is not a benign entity in our population and it needs to be closely followed
for development of Hypertension and other cardiovascular complications.
Keywords: White Coat Hypertension, Ambulatory blood pressure, Hypertension (JPMA 61:938; 2011).
phenomenon of BP variability. It was first described by Riva-
Rocci more than 100 years ago.6 It is a condition in which BP
is persistently elevated in the presence of a doctor, but falls to
normal values when the patient leaves the medical
environment. It is defined as BP of 140/90 mm Hg or more
when measured in office but otherwise normal daytime
ambulatory pressure <135/85 mm Hg.5 Measurement of BP
by nurses or trained non-medical staff may reduce, but not
necessarily abolish, this effect. This condition can only be
detected by Ambulatory Blood Pressure Monitoring (ABPM)
or by home self-monitoring. Recent studies have shown that
as compared to casual or in-office BP measurements, ABPM
data is a more accurate reflection of patients' true or actual BP
and is therefore a better predictor of cardiovascular
outcomes.7WCH is a stage where BP is falsely elevated and
would not need immediate drug therapy and failure to
recognize this can lead to inappropriate use of
antihypertensive medications. This is also a prehypertensive
stage and these patients warrant tight surveillance.8
The prevalence of WCH is quite variable, depending
on the selection of the patient groups. Studies have shown that
WCH has an estimated prevalence ranging from 12% to 53%
dependent upon the population studied and the definition
used.9 To date very few studies have been conducted on the
prevalence and impact of WCH in Pakistan and the Asian
population.10,11 We therefore conducted this study to
determine the frequency of WCH in patients undergoing
ABPM at a tertiary care center and to compare Ambulatory
Blood Pressure (ABP) profiles of NT, WCHT and HT.
Patients and Methods
It was a descriptive cross-sectional study comprising
of 277 patients who were recommended ABPM at a tertiary
care hospital. The indications for ABPM included newly
diagnosed HTN, decision to start antihypertensive
medications, suspicion of WCH, uncontrolled HTN on
medications, syncope and high diurnal variation of BP. 
After approval from the ethical review committee
(ERC), all patients undergoing ABPM at Aga Khan
University Hospital (AKUH), Karachi, Pakistan over a 3-year
period with age >15 years were included in the study. Those
with incomplete ABPM data, less than 85% successful BP
readings and inadequate number of daytime and night-time
readings were excluded from the study.
A purposive convenient sampling technique was used.
A minimum sample size of 245 was required to estimate a 20%
prevalence of WCH with bond on error of 5% and alpha of 0.05. 
Ambulatory blood pressure was measured using
Space Labs 90217-1q (12), Health Care, U.S.A., a fully
automatic, non-invasive BP measuring device that utilizes the
Korotkoff sound technique. The device was preset to take BP
readings at 30 min intervals. Before applying the ABP
monitor, informed consent was taken from every patient and
the demographic details, clinical indication for the
application of ABP, and details of medications used, if any,
were recorded. The patients were explained the procedure
and the monitor was applied on the non-dominant arm.
Appropriately sized arm cuffs were used. All patients were
provided with a diary to record their regular activities, the
sleep and wake up timings, their medication schedule, if any,
and any symptoms experienced. After application of the
monitor, the patients were sent home and were advised to
carry on with their daily routines and asked to return after 24
hours. On the return visit, a manual BP reading was taken
before removing the cuff. If less than 85% of the readings
were successful, the patient was scheduled for a repeat study. 
The data was identified from a computer-generated
inquiry of patients seen at AKUH. AccuTrack software was
used for data collection. The data on ABPM was transferred to
this computer database comprising of demographics, BP, pulse
pressure and heart rate readings recorded at every 30 minutes
interval and presented in a graphical and tabulated form. The
mean 24-hour blood pressure was determined. The times
marking the beginning and end of the awake and asleep periods
obtained from the patient diary were used to categorize the
blood pressure measurements into the awake or asleep periods.
The study population was divided into 3 comparison groups
according to these results: Normotensives (NT), White Coat
Hypertensives (WCHT) and Hypertensives (HT).
Normotension was defined as daytime ambulatory
pressure of <135/85 mm Hg and night time ambulatory
pressure of <120/75.5White Coat Hypertension was defined
as BP of 140/90 mm Hg or more when measured in office but
otherwise normal daytime ambulatory pressure <135/85 mm
Hg.5 Hypertension was defined as daytime ambulatory
pressure of >135/85 mm Hg and night time ambulatory
pressure of >120/75.5 The 24 hour blood pressure load
(percentage of systolic blood pressure (SBP) readings greater
than 140 mmHg or diastolic blood pressure (DBP) readings
greater than 90 mmHg during the awake hours and/or 120
and 80 mmHg, respectively, during sleep), the awake blood
pressure load (percentage of readings greater than 140 and 90
mmHg for the SBP and DBP, respectively, during the awake
period) and sleep blood pressure load (percentage of SBP
readings greater than 120 mmHg or DBP readings greater
than 80 mmHg during the sleep hours) were determined.
Mean Arterial Pressure (MAP) was calculated as 2/3 of DBP
plus 1/3 of SBP and Pulse Pressure (PP) was calculated as
SBP minus DBP. The nocturnal dip in BP was calculated
(according to American Heart Association) using the
following formula:
Dip= (1-sleep SBP/awake SBP)*100%
The patients were then classified according to the
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dipping status into the following groups: a. Dip<0% (increase
in nocturnal BP): Reverse Dippers, b. Dip between 0-10%:
Non-Dippers, c. Dip between 10-20%: Dippers and, d. Dip
>20%: Extreme Dippers.
Statistical Analysis:
SPSS version 15 was used for analysis, mean and
standard deviation were calculated for quantitative variables
and frequency and percentage for qualitative variables. Analysis
of variance was used to compare quantitative variables among
3 groups and chi square test for qualitative variables.
Results
A total of 277 patients were included with a mean age
of 48.98±17.52 years. There was a male predominance
comprising of 189 (68.2%) men whereas 88 ( 31.8%) were
females. Amongst these, 117 (42.2%) patients were known
HT while 160 (57.8%) were referred with the likely diagnosis
of HTN. The average SBP of all the patients was
126.76±12.49 mmHg and the average DBP was
76.16±8.83mmHg. The average systolic load was 31.3±27 %
and the average diastolic load was 18.45±21.48%. 
MAP was found to be high in 32.5% of the patients
while 43% of the patients had a high PP. Of the 277 patients
6.9% were reverse dippers, 43.3% were non-dippers, 48.8%
were dippers and 5.1% were extreme dippers. WCH was
present in 46 patients giving a prevalence of 16.6%.
Fifty nine (21%) patients were NT, 46 (16.6%) were
WCHT and 172 (62.1%) were HT. The mean age of NT was
40.80±14.11 years, WCHT was 37.72±14.58 years and HT was
54.80±16.76 years (p <0.001) (Figure-1). The male to female
ratio in NT was 3.9:1, WCHT was 3.2:1 and HT was 1.6:1.
Figure-2 shows the comparison of average overall
systolic load, MAP, PP and loss of nocturnal dip in NT,
WCHT and HT. The overall average SBP in NT was
118.69±6.61mmHg, WCHT was 120.57±6.71 mmHg and HT
was 131.18±13.14 mm Hg (p <0.001). The overall systolic
load in NT was 12.98±15.21, WCHT was 15.86±14.12 and
HT was 41.71±28.21 (p <0.001). The overall average MAP in
NT was 90.17±5.02, WCHT was 90.17±5.08 and HT was
Vol. 61, No. 9, September 2011 940
Table: 24-hour, day-time and night-time ABPM profile of NT, WCHT and HT.
NT WCHT HT P value
24-hour ABPM profile of NT, WCHT and HT
Av. SBP 118.69±6.61 120.57±6.71 131.18±13.14 <0.001
Sys. HTN Load 12.98±15.21 15.86±14.12 41.71±28.21 <0.001
Av. DBP 75.86±5.38 74.67±5.42 76.65±10.36 0.388
Dias. HTN Load 13.56±13.96 12.62±11.57 21.69±24.80 0.005
Av. MAP 90.17±5.02 90.17±5.08 96.08±9.21 <0.001
Av. PP 43.56±6.29 46.20±6.49 54.65±12.86 <0.001
Daytime ABPM profile of NT, WCHT and HT
Av. SBP 121.03±16.15 124.59±7.24 134.92±13.51 <0.001
Sys. HTN Load 11.04±16.73 11.63±15.43 37.68±30.40 <0.001
Av. DBP 79.05±5.67 77.70±5.81 79.43±10.77 0.526
Dias. HTN Load 14.83±16.85 11.46±12.15 21.21±25.52 0.013
Av. MAP 93.69±5.25 93.41±5.44 99.15±9.41 <0.001
Av. PP 43.83±6.12 47.65±7.19 55.67±13.19 <0.001
Night time ABPM profile of NT, WCHT and HT
Av. SBP 107.49±15.17 111.59±8.09 122.83±14.96 <0.001
Sys. HTN Load 17.88±21.07 24.03±23.22 51.57±33.86 <0.001
Av. DBP 78.47±78.23 67.74±6.84 70.27±11.00 0.256
Dias. HTN Load 12.36±17.23 14.01±18.85 20.63±27.11 0.040
Av. MAP 82.19±6.43 83.07±6.62 89.10±10.71 <0.001
Av. PP 41.25±5.65 44.17±6.58 52.86±12.62 <0.001
NT-Normotensives, WCHT-White Coat Hypertensives, HT-Hypertensives, SBP-Systolic Blood Pressure,
DBP-Diastolic Blood Pressure, PP-Pulse Pressure, MAP-Mean Arterial Pressure.
Figure-1: Age Distribution of NT, WCHT and HT. NT-Normotensives, WCHT-
White Coat Hypertensives, HT-Hypertensives.
96.08±9.21 (p <0.001). The overall average PP in NT was
43.56±6.29, WCHT was 46.20±6.49 and HT was
54.65±12.86 (p <0.001) (Table). Similarly table also shows
comparison of day time and night time profiles of NT, WCHT
and HT. Loss of nocturnal dip was seen in 42.4% of NT,
47.8% of WCHT and 53.5% of HT (Figure-2). 
Discussion
The prevalence of WCH in our study population was
16.6% which is parallel to findings of Dolan and Stanton as
the prevalence of WCH in their robust study of 5716 patients
was 15.4%.8A similar prevalence has also been noted in other
studies.13,14 However, prevalence of WCH is quite variable,
depending on the selection of the patient groups and studies
have suggested a prevalence of WCH between 12 and 54%.9
A study done in Lahore, Pakistan by Aziz et al. showed that
the prevalence of WCH in our society is 26.6%.10 The
difference was probably due to a different definition applied
for classification of WCH as distinction was not made
between WCH and White Coat Effect (WCE), which is a
similar phenomenon of raised office BP readings and
otherwise controlled BP in diagnosed hypertensives. 
There is a significant peak of WCH in third decade in
our study population which is comparable to the study of
Helvaci and Seyhanli3 which showed that WCH peaks in
third and fourth decade. Pickering13 also found that WCH
was more common in younger age groups as compared to NT
and HT. But some studies show that older age groups have
more prevalence of WCH.8
White Coat Hypertension has an intermediate position
between NT and HT. Prognostic factors like MAP, PP and
systolic loads were higher in WCHT compared to NT but
lower as compared to HT in our study. Loss of nocturnal dip
was also more common in WCHT as compared to NT but not
as common as in HT. Hence previously considered as a
completely benign condition, WCH has now been realized to
be of intermediate adverse outcome between that of NT and
HT. Our data clearly show that WCH is indeed a
prehypertensive state. The comparison of profiles of NT,
WCHT and HT indicate a continuum from NT to WCHT to
HT. Gustavsen14 showed that WCH is a prehypertensive state
941 J Pak Med Assoc
Figure-2: Average Overall Systolic Load, PP, MAP and Loss of Nocturnal Dip in NT, WCHT and HT. NT-Normotensives, WCHT-White Coat Hypertensives, HT-Hypertensives.
since 70.5% of patients in the WCH group developed
established hypertension during follow-up compared to
43.1% in the NT group. It was reported in the Ohasama
study15 that WCH is a risk factor for the development of
home HTN. Again, in an 8-year follow-up study, 46.9% of
subjects with WCH and 22.2% of NT subjects progressed to
HTN.16 Verdecchia et al17 reported that in their follow-up
study, 37% subjects with WCH spontaneously evolved into
sustained HTN, with accompanying increases in left
ventricular mass. Among those with baseline daytime
ABP<130/80mmHg, 20% developed established HTN. High
PP is an independent marker of preclinical cardiovascular
damage in relatively young patients with primary
hypertension and, therefore, can be useful for identifying
those at higher risk of cardiovascular events.18 A meta-
analysis in 2000, which combined the results of several
studies of 8,000 elderly patients in all, found that a 10 mm Hg
increase in PP increased the risk of major cardiovascular
complications and mortality by nearly 20%.19A high 24 hour
systolic load may be associated with an adverse
cardiovascular risk profile. Abnormal systolic loads can lead
to myocardial hypertrophy and hyperplasia.20 A study by
Sesso and Stampfer21 shows that average SBP, DBP, and
MAP are all strongly associated with an increased CVD risk
in younger men. Nocturnal HTN is associated with increased
cardiovascular complications.22 Loss of nocturnal dip is also
an earlier sign of HTN which means that WCHT have a
higher chance of developing HTN as compared to NT.
WCH is an important entity to recognize at an earlier
stage as its future implications on developing HTN are still
contradictory. There are very few long-term prospective studies
to compare prognosis of WCH and HTN. Some studies have
shown that WCH does not carry a higher risk for the
development of cardiovascular events as compared to NT.23,24
In contrast, many studies have suggested that WCH was
associated with significant end-organ damage with evidence of
significant LVH, greater intimal-medial thickness and plaque
index and more albuminuria than normotensives.25,26Although
we did not follow our patients who had WCH, but we found
that blood pressure trends in these patients were intermediate
between NT and HT. This highlights the importance of earlier
recognition of WCH in our population.
The limitation of our study is that our sample size is
small and it is a single center study so the results cannot be
generalized to the whole population. 
Our prevalence study has identified factors (PP, MAP,
systolic load and nocturnal hypertension) which are more
common in WCHT and have also been found to be detrimental
in the long term in the world literature. Hypertension is
endemic in the Pakistani population and the disease seems to
be starting at a younger age. Therefore, an outcome study in
our population would be worthwhile to identify the long term
behaviour of these adverse parameters and their translation
into cardiovascular morbidity and mortality. Strategies to
target these early occurring parameters and identifying WCH
group may be prudent and cost effective.
Conclusion
Our study has shown a prevalence of WCH which is
similar to many populations globally. All parameters of
hypertension are more prevalent in WCH group when
compared to normotensives, which signifies that WCH is not
a benign entity in our population and should be closely
followed for development of HTN and other cardiovascular
complications.
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